FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a conjugate of a ligand with a cytotoxic drug of general formula PC-LD, a method for its preparation and pharmaceutical compositions containing it for preparing medicinal agents for treating cancer.
EFFECT: disclosed is a conjugate of a ligand with a cytotoxic drug, a method for production thereof and use.
18 cl, 5 tbl, 53 ex
| Title | Year | Author | Number |
|---|---|---|---|
| C-ARYL GLUCOSIDE DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF | 2011 |
|
RU2606501C2 |
| POLYCYCLIC DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR PHARMACEUTICAL APPLICATION | 2012 |
|
RU2621039C1 |
| DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS | 2014 |
|
RU2662951C2 |
| DERIVATIVES OF DOLAPROIN-DOLAIZOLEIN PEPTIDES | 2015 |
|
RU2747989C2 |
| DERIVATIVES OF PYRROLOPYRIMIDINE USEFUL AS JAK-KINASES INHIBITORS | 2012 |
|
RU2618673C2 |
| CONJUGATE OF ANTI-IGF-1R ANTIBODY WITH DRUG AND USE THEREOF FOR TREATING CANCER | 2015 |
|
RU2692563C2 |
| OXOTHIOIMIDAZOLINE DERIVATIVES, METHODS FOR THEIR PRODUCTION AND APPLICATION IN MEDICINE AS ANDROGEN RECEPTOR INHIBITORS | 2013 |
|
RU2639145C2 |
| ANTIBODY AND MEDICINAL AGENT CONJUGATE AND USE THEREOF FOR TREATING CANCER | 2015 |
|
RU2685259C2 |
| BISULFATE OF JANUS KINAZE (JAK) INHIBITOR AND METHOD FOR ITS PREPARATION | 2014 |
|
RU2665680C2 |
| PIPERIDINE DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2016 |
|
RU2730508C2 |
